Skip to main content

Zantac and Generic Ranitidine Linked to Cancer. We Can Help.

On September 13, 2019, the FDA warned that common heartburn medication, Zantac, and other generic products containing Ranitidine, have been shown to lead to the formation of NDMA, a human carcinogen. A carcinogen is any substance that can lead to the formation of cancer. In April of 2020, the FDA announced that Zantac should be immediately pulled from the market due to this NDMA contamination. Many drugstores are now removing Zantac and generic Ranitidine products off their shelves.

Scientific research has demonstrated a clear link between Ranitidine, the active ingredient in Zantac, and NDMA. Notably, when Ranitidine comes into contact with water, it causes a chemical reaction that leads to the formation of NDMA. NDMA is used in industrial lubricants and rocket fuel, and is a by-product of gasoline refining and the treatment of wastewater containing nitrogen.

Despite this information being available to the drug makers, they chose not to disclose the risk to the government or to consumers. If you or a loved one took Zantac or Ranitidine for at least 90 days prior to being diagnosed with any form of cancer, you may be entitled to compensation. Even if your loved one has passed away, you may still be eligible. Call our office at 800-343-8537 and one of our attorneys will be able to advise you of your options and make sure you don’t miss any filing deadlines.